Development of a Potent and Selective G2A (GPR132) Agonist by Hernandez-Olmos, Victor, Heering, Jan, Marinescu, Beatrice, Schermeng, Tina, Ivanov, Vladimir V., Moroz, Yurii S., Nevermann, Sheila, Mathes, Marius, Ehrler, Johanna H. M., Alnouri, Mohamad Wessam, Wolf, Markus, Haydo, Alicia S., Schmachtel, Tessa, Zaliani, Andrea, Höfner, Georg, Kaiser, Astrid, Schubert-Zsilavecz, Manfred, Beck-Sickinger, Annette G., Offermanns, Stefan, Gribbon, Philipp, Rieger, Michael A., Merk, Daniel, Sisignano, Marco, Steinhilber, Dieter, Proschak, Ewgenij

Get full text

ADAMTS-7 Modulates Atherosclerotic Plaque Formation by Degradation of TIMP-1 by Sharifi, M. Amin, Wierer, Michael, Dang, Tan An, Milic, Jelena, Moggio, Aldo, Sachs, Nadja, von Scheidt, Moritz, Hinterdobler, Julia, Müller, Philipp, Werner, Julia, Stiller, Barbara, Aherrahrou, Zouhair, Erdmann, Jeanette, Zaliani, Andrea, Graettinger, Mira, Reinshagen, Jeanette, Gul, Sheraz, Gribbon, Philip, Maegdefessel, Lars, Bernhagen, Jürgen, Sager, Hendrik B., Mann, Matthias, Schunkert, Heribert, Kessler, Thorsten

Get full text

Ibuprofen, Flurbiprofen, Etoricoxib or Paracetamol Do Not Influence ACE2 Expression and Activity In Vitro or in Mice and Do Not Exacerbate In-Vitro SARS-CoV-2 Infection by de Bruin, Natasja, Schneider, Ann-Kathrin, Reus, Philipp, Talmon, Sonja, Ciesek, Sandra, Bojkova, Denisa, Cinatl, Jindrich, Lodhi, Imran, Charlesworth, Bruce, Sinclair, Simon, Pennick, Graham, Laughey, William F, Gribbon, Philip, Kannt, Aimo, Schiffmann, Susanne

Get full text

Drug repurposing for the treatment of COVID-19: Targeting nafamostat to the lungs by a liposomal delivery system by Reus, Philipp, Guthmann, Hadar, Uhlig, Nadja, Agbaria, Majd, Issmail, Leila, Eberlein, Valentina, Nordling-David, Mirjam M, Jbara-Agbaria, Doaa, Ciesek, Sandra, Bojkova, Denisa, Cinatl, Jindrich, Burger-Kentischer, Anke, Rupp, Steffen, Zaliani, Andrea, Grunwald, Thomas, Gribbon, Philip, Kannt, Aimo, Golomb, Gershon

Get full text

A machine learning method for the identification and characterization of novel COVID-19 drug targets by Schultz, Bruce, DeLong, Lauren Nicole, Masny, Aliaksandr, Lentzen, Manuel, Raschka, Tamara, van Dijk, David, Zaliani, Andrea, Fröhlich, Holger

Get full text

Characterization of ACE Inhibitors and AT1R Antagonists with Regard to Their Effect on ACE2 Expression and Infection with SARS-CoV-2 Using a Caco-2 Cell Model by Reus, Philipp, Schneider, Ann-Kathrin, Ulshöfer, Thomas, Henke, Marina, Bojkova, Denisa, Cinatl, Jindrich, Ciesek, Sandra, Geisslinger, Gerd, Laux, Volker, Grättinger, Mira, Gribbon, Philip, Schiffmann, Susanne

Get full text